We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Reneuron Group Plc | LSE:RENE | London | Ordinary Share | GB00BF5G6K95 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.05 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 530k | -5.41M | -0.0946 | -0.32 | 1.74M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/9/2016 14:26 | A question for the experts.... My Rene RSI indicator is showing zero for the past few days. I understand that any number below 30 is over sold and above 70 is over bought. With recent volumes being so low does the indicator actually mean anything? A bit like British Bulls low volume forecasts for Rene providing the prediction after the event? Best wishes. Freddie | fredd1eboy | |
29/9/2016 13:30 | i expect great results from the treatments based upon the first SAFETY clinical trials and dont understand that the share price didnt move on the safety results! AIMHO | stewart_25 | |
29/9/2016 12:30 | spot on john. plenty of news due soon...Ren001, Ren009 promised then followed by exosome, new manufacturing facility licensing, Ren003. Best wishes Freddie ps... wish I had kept some sareum rather than sell and buy more Rene with the proceeds. Hindsight's a great thing!!!!! | fredd1eboy | |
29/9/2016 10:56 | This share will take 3-5 years to reach its potential. Of course there's huge risk but the reward potential is also huge. Share price recovery will depend on positive clinical trial data, next update on the stroke therapy due before year end, as Freddie has pointed out. Also big seller in the background isn't helping, which is also causing weak PI's to capitulate. | johnb5 | |
29/9/2016 07:58 | The darkest hour is often before the dawn. However this is getting really tedious. Just keep them in the bottom drawer and forget about them | yachtmaster2 | |
29/9/2016 07:32 | Sorry to hear that easwarareddy. Best of luck with your alternative investment choice. Freddie | fredd1eboy | |
29/9/2016 07:00 | Pulling out of here. Been in here nearly a year or two with no recovery whatever news as come out. Nearly 50 percent loss on it. | easwarareddy | |
28/9/2016 16:50 | Hi Stewart. Next update promised by end December. However I would never be surprised to hear news earlier.....ie messa conference next week etc. So Dec 25th is long stop. If true to course we will see a gradual recovery in share price coming soon. Best wishes Freddie | fredd1eboy | |
28/9/2016 14:50 | Surely we are due news sometime soon. did i see an update due Q3 2016 mentioned? | stewart_25 | |
26/9/2016 14:38 | Some large buying going on in the background. MM's prepared to take 1.5million in one online transaction. | johnb5 | |
24/9/2016 07:59 | RedX was mntioned by Midas in the mail,if you have got a lot of shares in any company and you are a fund manager you are going to talk up your selections | diamond fibre | |
23/9/2016 18:34 | Well done John. I'm into Woodford too. His 34% investment along with Chris Evans Arthurian, and Welsh Sciences taking it to over 50% has been my saviour. At least the base line was 5p 12 months ago and I'm sure will return within the next few weeks, hopefully before news. Either way I'll be a lot happier when the selling is confirmed to be over. Guess we may know next week. Best of luck for us both. Have a good weekend. Freddie | fredd1eboy | |
23/9/2016 18:08 | I'm heavily invested in the Woodford income fund Freddie, which lead me to invest directly in Reneuron. Like you I now have a good few million of these bad boys, but I managed to buy most on the dips so average just over 2.5p. Woodford has talked up Rene's prospects in his last two monthly updates. If Woodford is excited about this share then that'll do for me. He's no mug, but as we all know it's now down to the clinical trial data read outs. However all the signs are looking good. Best wishes John. | johnb5 | |
23/9/2016 16:40 | I think rene is way better funded and much closer to success than redx !!! | 22richyrich | |
23/9/2016 16:39 | I was thinking of redx which has doubled on what seems less than amazing update last week ! | 22richyrich | |
23/9/2016 16:37 | I was fortunate to buy fum at 50p after their news 2 weeks ago and made quick double in 24 hrs sold at 90p and bought 75k shares in rene with profit | 22richyrich | |
23/9/2016 15:41 | Agree richy. All we need is some really good news and as news is promised by end December if not sooner we may well soon see a recovery back up to 5p plus prior to the actual news release. That's what I'm hoping for and if so I have made sure I wont miss the boat. Its poo or bust for me. Not long to wait now. Are you topped up or pondering further investment? Best wishes. Freddie | fredd1eboy | |
23/9/2016 15:01 | Ive noticed recently that biotech firms have seen some dramatic share price increases on what sometimes seems less than overwhelming news so see rene as a potential big winner with or without big news cos a tip on twitter nowadays can set off big share price rises esp here imo given its attraction as low pennys punt.. | 22richyrich | |
23/9/2016 14:50 | So much news to come john. Methinks we will be looking backing back and laughing at the current share price our big investment bosom buddies have taken us down to. I'm just pleased to have taken the opportunity over the past weeks to average right down to an share price which will hopefully blossom soon and grow into a thing of beauty. Best wishes Freddie | fredd1eboy | |
23/9/2016 13:18 | Dire share price for a company with a potential cure for cancer. | johnb5 | |
23/9/2016 11:01 | Anyone got the presentation by Dr Sinden on the 21st? | dickbush | |
23/9/2016 09:09 | Good morning small crow and stewart. Agreed the share price is currently silly. My guess is that Woodford is selling out at a loss in one fund (booking against taxable loss for year) and buying into the Trust where after 2 years AIM profits are cg free. When the brakes come off we will shoot up to 5p plus. That is dependent on good news and there's plenty of news promised. In the meantime I have been enjoying buying as and when funds allow. If I'm wrong so are the big boys but all the pointers appear to align to potential significant upside. Best wishes. Freddie | fredd1eboy | |
23/9/2016 08:39 | freddie- shame share price doesn't reflect what we believe to be successful ... | stewart_25 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions